Arax Advisory Partners’s Tvardi Therapeutics TVRD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.5K	Sell	8,333 -67	-0.8%	-$262	﹤0.01%	1968
2025 Q4	$36.1K	Buy	8,400 +6,173	+277%	+$55.3K	﹤0.01%	1790
2025 Q3	$86.8K	Buy	2,227 +1,360	+157%	+$38.7K	﹤0.01%	1585
2025 Q2	$20.2K	Sell	867 -2	-0.2%	-$47	﹤0.01%	1655
2025 Q1	$13.2K	Buy	869 +667	+330%	+$10.1K	﹤0.01%	1474
2024 Q4	$3.71K	Sell	202 -8	-4%	-$87	﹤0.01%	1842
2024 Q3	$2.33K	Hold	210	–	–	﹤0.01%	2007
2024 Q2	$1.95K	Buy	210 +8	+4%	+$191	﹤0.01%	1978
2024 Q1	$6.62K	Hold	202	–	–	﹤0.01%	853
2023 Q4	$5.41K	Hold	202	–	–	﹤0.01%	876
2023 Q3	$12.2K	Buy	202 +139	+221%	+$13K	﹤0.01%	676
2023 Q2	$6.44K	Buy	63 +41	+186%	+$5.65K	﹤0.01%	807
2023 Q1	$3.81K	Hold	22	–	–	﹤0.01%	906
2022 Q4	$8.32K	Buy	22 +1	+5%	+$380	﹤0.01%	675
2022 Q3	$7K	Hold	21	–	–	﹤0.01%	732
2022 Q2	$7K	Hold	21	–	–	﹤0.01%	713
2022 Q1	$9K	Hold	21	–	–	﹤0.01%	677
2021 Q4	$9K	Hold	21	–	–	﹤0.01%	690
2021 Q3	$12K	Buy	21 +20	+2,000%	+$10K	﹤0.01%	624
2021 Q2	$0	Buy	+1	New	+$634	﹤0.01%	937